Staphylococcus simulans recombinant lysostaphin: Production, purification, and determination of antistaphylococcal activity
- 269 Downloads
Staphylococcus simulans lysostaphin is an endopeptidase lysing staphylococcus cell walls by cleaving pentaglycine cross-bridges in their peptidoglycan. A synthetic gene encoding S. simulans lysostaphin was cloned in Escherichia coli cells, and producer strains were designed. The level of produced biologically active lysostaphin comprised 6-30% of total E. coli cell protein (depending on E. coli M15 or BL21 producer) under batch cultivation conditions. New methods were developed for purification of lysostaphin without affinity domains and for testing its enzymatic activity. As judged by PAGE, the purified recombinant lysostaphin is of >97% purity. The produced lysostaphin lysed cells of Staphylococcus aureus and Staphylococcus haemolyticus clinical isolates. In vitro activity and general biochemical properties of purified recombinant lysostaphin produced by M15 or BL21 E. coli strains were identical to those of recombinant lysostaphin supplied by SigmaAldrich (USA) and used as reference in other known studies. The prepared recombinant lysostaphin represents a potential product for development of enzymatic preparation for medicine and veterinary due to the simple purification scheme enabling production of the enzyme of high purity and antistaphylococcal activity.
KeywordsStaphylococcus simulans Escherichia coli recombinant lysostaphin heterologous expression liquid chromatography lytic activity Staphylococcus sp. clinical isolates
partial inhibition zone
total inhibition zone
Unable to display preview. Download preview PDF.
- 11.Sharma, R., Sharma, P. R., Choudhary, M. L., Pande, A., and Khatri, G. S. (2006) Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli, Protein Express. Purif., 45, 206–215.CrossRefGoogle Scholar
- 13.Recsei, P. A. (1990) Expression of recombinant mature lysostaphin, US Patent 4931390.Google Scholar
- 17.Khatri, G. S., and Sharma, R. (2009) Expression of recombinant mature lysostaphin, Patent EP1224271 B1.Google Scholar
- 18.Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory Press, New York.Google Scholar
- 19.Schindler, C. A., and Schuardt, V. T. (1965) Purification and properties of lysostaphin: a lytic agent for the Staphylococcus aureus, Biochim. Biophys. Acta, 97, 242250.Google Scholar
- 22.Huang, Q., Lu, H., and Lu, W. (2009) Method of Secretory Expression of Lysostaphin in Escherichia coli at High Level, Patent WO 20090186380.Google Scholar
- 26.Yang, X.-Y., Li, C.-R., Lou, R.-H., Wang, Y.-M., Zhang, W.-X., Chen, H.-Z., Huang, Q.-S., Han, Y.-X., Jiang, J.D., and You, X.-F. (2007) In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China, J. Med. Microbiol., 56, 71–76.CrossRefGoogle Scholar